Sarepta Therapeutics and Genethon announce gene therapy research collaboration for Duchenne muscula

(AFM-Téléthon) Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Genethon have signed a gene therapy research collaboration to jointly develop treatments for Duchenne muscular dystrophy (DMD).

from EurekAlert! - Social and Behavioral Science http://ift.tt/2tNN7wt